We are live on ! Find out more
TMO icon

Thermo Fisher Scientific

1,044 hedge funds and large institutions have $55.2B invested in Thermo Fisher Scientific in 2016 Q3 according to their latest regulatory filings, with 64 funds opening new positions, 332 increasing their positions, 458 reducing their positions, and 65 closing their positions.

New
Increased
Maintained
Reduced
Closed

19% more funds holding in top 10

Funds holding in top 10: 7893 (+15)

13% more call options, than puts

Call options by funds: $226M | Put options by funds: $201M

7% more capital invested

Capital invested by funds: $51.5B → $55.2B (+$3.71B)

0.13% less ownership

Funds ownership: 88.79%88.67% (-0.13%)

2% less first-time investments, than exits

New positions opened: 64 | Existing positions closed: 65

1% less funds holding

Funds holding: 1,0551,044 (-11)

28% less repeat investments, than reductions

Existing positions increased: 332 | Existing positions reduced: 458

Holders
1,044
Holders Change
-11
Holders Change %
-1.04%
% of All Funds
27.85%
Holding in Top 10
93
Holding in Top 10 Change
+15
Holding in Top 10 Change %
+19.23%
% of All Funds
2.48%
New
64
Increased
332
Reduced
458
Closed
65
Calls
$226M
Puts
$201M
Net Calls
+$25.2M
Net Calls Change
-$33.8M
Name Holding Trade Value Shares
Change
Change in
Stake
UBS Group
26
UBS Group
Switzerland
$440M +$19.8M +128,683 +5%
Dimensional Fund Advisors
27
Dimensional Fund Advisors
Texas
$436M -$522K -3,386 -0.1%
GCM
28
Glenview Capital Management
New York
$427M -$26.5M -171,924 -6%
AAMU
29
Amundi Asset Management US
Massachusetts
$421M +$7.93M +51,433 +2%
Ameriprise
30
Ameriprise
Minnesota
$414M -$15.9M -103,471 -4%
JHIU
31
Janus Henderson Investors US
Colorado
$406M +$89.8M +582,943 +30%
JP Morgan Chase
32
JP Morgan Chase
New York
$400M -$7.04M -45,698 -2%
Select Equity Group
33
Select Equity Group
New York
$363M -$10.8M -70,231 -3%
FAM
34
Fred Alger Management
New York
$322M -$38.2M -247,929 -11%
UBS AM
35
UBS AM
Illinois
$319M +$57.3M +372,076 +23%
ClearBridge Investments
36
ClearBridge Investments
New York
$314M +$16M +103,761 +6%
PAMU
37
Pictet Asset Management (UK)
United Kingdom
$301M -$3.91M -25,403 -1%
Winslow Capital Management
38
Winslow Capital Management
Minnesota
$299M +$290M +1,882,651 New
Legal & General Group
39
Legal & General Group
United Kingdom
$281M -$5.79M -37,585 -2%
FPA
40
First Pacific Advisors
California
$267M -$17.4M -112,680 -6%
BA
41
BlackRock Advisors
Delaware
$256M +$3.28M +21,312 +1%
Luther King Capital Management (LKCM)
42
Luther King Capital Management (LKCM)
Texas
$250M -$989K -6,417 -0.4%
Royal Bank of Canada
43
Royal Bank of Canada
Ontario, Canada
$243M -$30.5M -197,978 -11%
Goldman Sachs
44
Goldman Sachs
New York
$237M +$27.5M +178,656 +14%
Schroder Investment Management Group
45
Schroder Investment Management Group
United Kingdom
$236M -$30.4M -197,590 -12%
Lazard Asset Management
46
Lazard Asset Management
New York
$228M -$12.4M -80,178 -5%
Charles Schwab
47
Charles Schwab
California
$210M +$7.69M +49,886 +4%
Bessemer Group
48
Bessemer Group
New Jersey
$207M +$6.89M +44,744 +4%
FPP
49
Findlay Park Partners
United Kingdom
$206M +$20.8M +135,000 +12%
New York State Common Retirement Fund
50
New York State Common Retirement Fund
New York
$197M +$9.96M +64,655 +6%

TMO Hedge Fund Activity: Q3 2016 in Review

1,044 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Thermo Fisher Scientific (TMO) for Q3 2016, worth a combined $55.2B — up 7.2% from $51.5B a quarter earlier.

Sellers outnumbered buyers: 65 funds closed out of TMO and 64 opened new positions — a net loss of 1 holder — while 458 trimmed existing stakes and 332 added.

The largest buyer was Winslow Capital Management, opening a new position worth an estimated $290M. The largest seller was Capital Research Global Investors, cutting an estimated $250M.

  • 1,044 institutional investors held Thermo Fisher Scientific (TMO) as of Q3 2016, down from 1,055 in Q2 2016.
  • Funds reported $55.2B of Thermo Fisher Scientific stock for Q3 2016, up 7.2% quarter-over-quarter.
  • 64 funds opened new Thermo Fisher Scientific positions in Q3 2016 and 65 closed out, a net change of -1 holder.
  • The largest Thermo Fisher Scientific buyer in Q3 2016 was Winslow Capital Management, an estimated $290M added.
  • The largest Thermo Fisher Scientific seller in Q3 2016 was Capital Research Global Investors, an estimated $250M sold.

Based on aggregated 13F filings for Q3 2016.